GlassScriptPhysician profile
Ross Blair
NPI 1437735552
$1,395.60
in general payments reported to CMS, 2019-2025
10 companies · $1,224 in 2025
The $1,224 reported for 2025 was more than what 90% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $20.00 · 2023: $29.01 · 2024: $123 · 2025: $1,224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $791 · Food and Beverage: $585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $790.63 |
| Food and Beverage | $584.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $987.43 | 2024-2025 | Linq II, Na |
| Philips North America LLC | $87.27 | 2025 | Ecc Solutions, Mcot, Ambulatory Monitoring & Diagnostics Undivided |
| Amgen INC. | $82.76 | 2024-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $81.12 | 2024-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $47.37 | 2025 | Verquvo, Capvaxive |
| Medicomp INC | $29.01 | 2023 | Telepatch Cardiac Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $22.01 | 2025 | |
| Esperion Therapeutics, INC. | $20.01 | 2025 | Nexletol |
| Alkermes, INC. | $20.00 | 2022 | |
| Pfizer INC. | $18.62 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Blair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.